Pemvidutide
Alcohol Use Disorder (AUD)
Altimmune, Inc.protein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Alcohol Use Disorder (AUD) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Naltrexone Boston Medical Center | Phase 4 | BB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- Boston Medical Center | Phase 2 | B |
TEONANACATL Centre for Addiction and Mental Health | Phase 2 | CCC |
Tirzepatide South West Sydney Local Health District | Phase 2 | CCC |
Zonisamide Yale University | Phase 2 | CCC |
View all 19 →
Same molecule, other indications
Pemvidutide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →